EXAS Exact Sciences Corp.
10,976
$59.48
$1.93
(3.14%)
| Watchers | 10,976 |
| 52-Wk Low | $56.05 |
| 52-Wk High | $100.77 |
| Market Cap | $10.94B |
| Volume | 2,167.00 |
| 52-Wk High | $100.77 |
| 52-Wk Low | $56.05 |
Exact Sciences Stock Plunges On Q1 Earnings: What You Need To KnowBenzinga • about 13 hours ago
Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a...
Share to Feed
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $638 million for the first quarter ended March...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the company will present six abstracts on strategies and advancements for improving...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited...
Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024...
Exact Sciences Corp. (Nasdaq: EXAS) (the Company), a leading provider of cancer screening and diagnostic tests, today announced that on April 10, 2024 it entered into privately negotiated exchange...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present late-breaking data from the first analysis of the ASCEND-2 study demonstrating the...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its first quarter 2024 financial results after the...
Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) EVP Sarah Condella sold 2,000 shares of the business's stock in a transaction dated Monday, April 1st. The stock was sold at an average price of...